Course Content
Zambian Paediatric & Obstetrics-Gynecology (OB/GYN) Clinical Mastery

Neurodevelopmental Disorders 

Lesson Objectives

By the end of this lesson, learners should be able to:

  1. Define and identify common neurodevelopmental disorders in children.

  2. Recognize clinical features and screening tools for ADHD, ASD, and Cerebral Palsy.

  3. Understand supportive, pharmacological, and multidisciplinary management approaches.

  4. Identify complications and referral criteria for specialized care.

Attention Deficit Hyperactivity Disorder (ADHD)

Description:
ADHD is a persistent pattern of inattention and/or hyperactivity-impulsivity lasting ≥6 months, negatively affecting social, academic, or occupational functioning.

Clinical Features:

Domain Signs & Symptoms
Inattentiveness Short attention span, easily distracted, difficulty listening, following instructions, organizing tasks, forgetfulness, avoidance of sustained mental effort
Hyperactivity / Impulsivity Excess motor activity, running, fidgeting, rapid speech, inability to remain seated, blurting answers, difficulty waiting, interrupting others

Investigations:

  • DSM-5 criteria

  • Vanderbilt Teacher Rating Scale

  • Symptoms present >6 months in ≥1 setting (home and school)

Treatment:

Type Intervention
Supportive Behavioral parent therapy, CBT, environment restructuring, classroom management, family therapy, play therapy, exercise, social skills training
Pharmacological Methylphenidate 5–20 mg 12-hourly (long-acting), short-acting 8-hourly, max 60 mg/day; Dextroamphetamine 10–60 mg 12-hourly

Note: If stimulants are unavailable or ineffective, other psychotropics may be used under specialist guidance. Refer to paediatrician/neurologist.

Autism Spectrum Disorder (ASD)

Description:
ASD is a neurodevelopmental disorder with deficits in social communication and interaction and restricted, repetitive behaviors.

Screening Tools:

  • M-CHAT (16–30 months)

  • DSM-5 criteria

Clinical Features:

  • Lack of social interaction, delayed language, poor eye contact, repetitive behaviors (echolalia, hand-flapping), distress with minor changes, obsessive interests, unusual sensory reactions.

  • Developmental milestones: e.g., no pointing by 14 months, no pretend play by 18 months.

Treatment:

Type Intervention
Supportive Social skills interventions, family therapy, occupational therapy, early education, behavior modification, screen for comorbidities (ADHD, mood/anxiety)
Pharmacological For irritability/self-injurious behavior: Risperidone 0.01 mg/kg/day starting, maintenance 0.02–0.04 mg/kg/day (ages 5–12, <50 kg)

Referral:
Refer patients not responding to risperidone to psychiatrist, neurologist, or appropriate sub-specialist.

Cerebral Palsy (CP)

Description:
CP comprises non-progressive movement and posture disorders due to early brain injury, often associated with sensory, cognitive, and behavioral abnormalities.

Risk Factors:

  • Prematurity, SGA, multiple pregnancy, HIE, neonatal meningitis/sepsis

Types of CP:

Type Characteristics
Spastic Diplegia, hemiplegia, quadriplegia
Dyskinetic Dystonic, athetoid
Ataxic Ataxia
Global involvement Mixed features

Treatment:

Type Intervention
Medication Baclofen for spasticity, Levodopa for dystonia
Multidisciplinary Physiotherapy, occupational therapy, speech therapy, orthopaedics, family/caregiver support
Functional Assessment GMFCS (Gross Motor Function Classification System)

Complications:

  • Neurological: epilepsy, hydrocephalus, sensory deficits

  • Behavioral / Learning: sleep disturbance, depression, autistic features, learning difficulties

  • Gastrointestinal: dysphagia, reflux, constipation

  • Bone / Orthopaedic: osteoporosis, scoliosis, hip dislocation, fractures

  • Respiratory: aspiration, chest infections

  • Skin: drooling, pressure sores

  • Dental: poor hygiene, caries

  • Genito-urinary: neurogenic bladder

 

 

Bookmark